The University of Kansas Cancer Center – Westwood
Doctors Affiliated with this Treatment Facility
Contact Information
Richard and Annette Bloch Cancer Care Pavilion
2650 Shawnee Mission Parkway
Westwood, KS 66205
01. History
History of The University of Kansas Cancer Center
The Richard and Annette Bloch Cancer Care Pavilion provides expert cancer care in an outpatient setting. The facility, located in Westwood, Kansas, gets its name from husband and wife pair, Richard and Annette Bloch. Their foray into cancer care began when Richard was diagnosed with terminal lung cancer in 1978.
The cancer care provided at The Richard and Annette Bloch Cancer Care Pavilion is all about personalization and ensuring the patient is at ease during their cancer journey. For instance, prior to a patient’s first visit they receive a personalized appointment guide to help them navigate their first time at the center.
While a cancer diagnosis is never easy receiving care from The Richard and Annette Bloch Cancer Care Pavilion is done in a way to minimize patient discomfort. The three-story building features many amenities to make a patient’s time there as enjoyable as possible. Included in the facility is a cafe, an accredited boutique and appearance center as well as complimentary valet parking for all patients. Providing these services helps comfort patients, like those with mesothelioma, receiving chemotherapy and radiation treatments.
02. Specializations
The University of Kansas Cancer Center Specializations
- Advanced imaging services
- Blood and marrow transplant
- Chemotherapy
- Outpatient laboratory services
- Pediatric oncology
03. Accreditations
The University of Kansas Cancer Center Accreditations
- U.S. News & World Reports Best Hospitals
- National Cancer Institute (NCI) Designated Cancer Center
04. Mesothelioma Clinical Trials
Mesothelioma Clinical Trials at The University of Kansas Cancer Center
The following clinical trials are in progress or actively recruiting participants at The University of Kansas Cancer Center:
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Breast Neoplasms, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms
Last Updated: April 28, 2021
Status: Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Cystadenocarcinoma, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Nerve Sheath Neoplasms, Gestational Trophoblastic Disease, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Adrenocortical Carcinoma, Sex Cord-Gonadal Stromal Tumors, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Neoplasms, Unknown Primary, Mixed Tumor, Mullerian, Carcinoma, Giant Cell
Last Updated: June 30, 2021
Status: Recruiting
Resources for Mesothelioma Patients
